SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-040888
Filing Date
2023-04-03
Accepted
2023-04-03 16:31:33
Documents
12
Period of Report
2023-03-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2311357d1_8k.htm   iXBRL 8-K 21712
  Complete submission text file 0001104659-23-040888.txt   197385

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pmn-20230329.xsd EX-101.SCH 3063
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmn-20230329_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmn-20230329_pre.xml EX-101.PRE 22616
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2311357d1_8k_htm.xml XML 3712
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 23793179
SIC: 2834 Pharmaceutical Preparations